Angel News

Back to Homepage

22nd September 2020

Ceryx Medical secures £575,000 to develop world-first curative therapy for heart failure

Ceryx Medical, a bioelectronics startup working towards the world’s first curative therapy for heart failure, has secured a £575,000 seed round.

The funding, which comprises a £250,000 commitment from the Development Bank of Wales, £225,000 from angel investors, and £100,000 from the University of Bristol’s Enterprise Investment Fund, managed by leading UK university spinout investor ParkWalk, will enable the company to grow its management and technology teams.


Register / Login now to read full story

In order to read the full story we need you to be registered with us, please click the links below to login or register.

Login / Register

Add a comment:




Enter the characters in the image shown:

Back to Homepage